The overall methylation frequency of CDKN2A in blood, pancreatic tissue and juice for pancreatic carcinoma were more than that in normal controls, suggesting a potential role of CDKN2A methylation analysis in diagnosing pancreatic cancer. Here, CDKN2A is linked to familial pancreatic carcinoma.